Amedisys Inc (AMED)

89.45 +3.50 (+4.07%) USD  |  NASDAQ  |  Dec 27, 10:08
More

Amedisys SG&A Expense (Quarterly): 198.34M for Sept. 30, 2024

SG&A Expense (Quarterly) Chart

View SG&A Expense (Quarterly) for AMED.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense Definition

View SG&A Expense Definition
Start Trial

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

View SG&A Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (Quarterly) Benchmarks

View SG&A Expense (Quarterly) Benchmarks
Start Trial
Chemed Corp 101.98M
Addus HomeCare Corp 62.80M
Regional Health Properties Inc 1.224M
OptimizeRx Corp 13.42M
Option Care Health Inc 157.00M